Extracellular vesicles released from ganglioside GD2-expressing melanoma cells enhance the malignant properties of GD2-negative melanomas. 2023

Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
Department of Biomedical Sciences, Chubu University College of Life and Health Sciences, Matsumoto 1200, Kasugai, Aichi, 487-8501, Japan.

Exosomes (small extracellular vesicles: EVs) have attracted increasing attention from basic scientists and clinicians since they play important roles in cell-to-cell communication in various biological processes. Various features of EVs have been elucidated regarding their contents, generation and secretion mechanisms, and functions in inflammation, regeneration, and cancers. These vesicles are reported to contain proteins, RNAs, microRNAs, DNAs, and lipids. Although the roles of individual components have been rigorously studied, the presence and roles of glycans in EVs have rarely been reported. In particular, glycosphingolipids in EVs have not been investigated to date. In this study, the expression and function of a representative cancer-associated ganglioside, GD2, in malignant melanomas was investigated. Generally, cancer-associated gangliosides have been shown to enhance malignant properties and signals in cancers. Notably, EVs derived from GD2-expressing melanomas enhanced the malignant phenotypes of GD2-negative melanomas, such as cell growth, invasion, and cell adhesion, in a dose-dependent manner. The EVs also induced increased phosphorylation of signaling molecules such as EGF receptor and focal adhesion kinase. These results suggest that EVs released from cancer-associated ganglioside-expressing cells exert many functions that have been reported as a function of these gangliosides and regulate microenvironments, including total aggravation of heterogeneous cancer tissues, leading to more malignant and advanced cancer types.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067128 Extracellular Vesicles Membrane limited structures derived from cell membranes and cytoplasmic material, and released into EXTRACELLULAR SPACE. They circulate through the EXTRACELLULAR FLUID and through the peripheral blood in the MICROVASCULATURE where cells, much larger, cannot, thereby affecting a variety of intercellular communication processes. Apoptotic Bodies,Exovesicles,Apoptotic Body,Bodies, Apoptotic,Body, Apoptotic,Exovesicle,Extracellular Vesicle,Vesicle, Extracellular,Vesicles, Extracellular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D059016 Tumor Microenvironment The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth. Cancer Microenvironment,Cancer Microenvironments,Microenvironment, Cancer,Microenvironment, Tumor,Microenvironments, Cancer,Microenvironments, Tumor,Tumor Microenvironments

Related Publications

Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
April 2018, International journal of oncology,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
March 2023, International journal of molecular sciences,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
October 2021, Cells,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
April 2005, Cancer research,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
August 2023, Stem cell research & therapy,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
May 2019, FEBS letters,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
April 2016, Nanomedicine (London, England),
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
October 2022, International journal of molecular sciences,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
April 2021, Cells,
Farhana Yesmin, and Keiko Furukawa, and Mariko Kambe, and Yuhsuke Ohmi, and Robiul Hasan Bhuiyan, and Mohammad Abul Hasnat, and Momoka Mizutani, and Orie Tajima, and Noboru Hashimoto, and Akiko Tsuchida, and Kei Kaneko, and Koichi Furukawa
December 2018, Biochimie,
Copied contents to your clipboard!